World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
113
Citations
56370
World Ranking
4881
National Ranking
151

Carlo Salvarani publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Carlo Salvarani sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,052 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Carlo Salvarani D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Carlo Salvarani sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 113 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Carlo Salvarani is affiliated with the University of Modena and Reggio Emilia in Italy and has an extensive body of work primarily in the field of Medicine, with a strong focus on Rheumatology. Their research covers significant subfields including Pulmonary and Respiratory Medicine, Immunology, Pathology and Forensic Medicine, and Genetics.

Salvarani's main research topics include:

  • Vasculitis and related conditions
  • Systemic Sclerosis and Related Diseases
  • Rheumatoid Arthritis Research and Therapies
  • Spondyloarthritis Studies and Treatments
  • Systemic Lupus Erythematosus Research
  • Psoriasis: Treatment and Pathogenesis
  • Otitis Media and Relapsing Polychondritis

Recent publications by Salvarani cover a range of subjects and have appeared in various recognized venues. Selected recent papers include:

  • "Rehabilitation Interventions for Post-Acute COVID-19 Syndrome: A Systematic Review," 2022, International Journal of Environmental Research and Public Health
  • "Uveitis and Other Ocular Complications Following COVID-19 Vaccination," 2021, Journal of Clinical Medicine
  • "Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows," 2020, Journal of Clinical Medicine
  • "Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting," 2020, Arthritis & Rheumatology
  • "Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation," 2020, Critical Care

Collaborations feature prominently in Salvarani's career, with frequent co-authors including:

  • Francesco Muratore
  • Federica Lumetti
  • Lorenzo Dagna
  • Chiara Marvisi
  • Dilia Giuggioli

Salvarani has published extensively in several journals, with a notable number of works appearing in:

  • Annals of the Rheumatic Diseases
  • Clinical and Experimental Rheumatology
  • Lara D. Veeken
  • Journal of Clinical Medicine
  • Expert Review of Clinical Immunology

In addition to journal articles, Salvarani has contributed to academic books, including a publication with Springer International Publishing titled Large and Medium Size Vessel and Single Organ Vasculitis released in 2021.

Best Publications

  • EULAR Recommendations for the management of primary small and medium vessel vasculitis

    C. Mukhtyar;L. Guillevin;M. C. Cid;B. Dasgupta

  • Trial of Tocilizumab in Giant-Cell Arteritis.

    John H Stone;Katie Tuckwell;Sophie Dimonaco;Micki Klearman

  • The International Criteria for Behçet's Disease (ICBD): A collaborative study of 27 countries on the sensitivity and specificity of the new criteria

    F. Davatchi;S. Assaad-Khalil;K. T. Calamia;J. E. Crook

  • Polymyalgia rheumatica and giant-cell arteritis.

    Carlo Salvarani;Fabrizio Cantini;Luigi Boiardi;Gene G. Hunder

  • Tocilizumab in patients with severe COVID-19: a retrospective cohort study

    Giovanni Guaraldi;Marianna Meschiari;Alessandro Cozzi-Lepri;Jovana Milic

  • Polymyalgia rheumatica and giant-cell arteritis

    Carlo Salvarani;Fabrizio Cantini;Gene G Hunder

  • EULAR recommendations for the management of Behçet disease

    G Hatemi;A Silman;D Bang;B Bodaghi

  • Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis.

    Jurgen Sota;Antonella Insalaco;Rolando Cimaz;Maria Alessio

  • EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice.

    Christian Dejaco;Sofia Ramiro;Christina Duftner;Florent L Besson

  • 2018 Update of the EULAR recommendations for the management of large vessel vasculitis.

    Bernhard Hellmich;Ana Agueda;Sara Monti;Frank Buttgereit

  • EULAR recommendations for the management of large vessel vasculitis

    C. Mukhtyar;L. Guillevin;M. C. Cid;B. Dasgupta

  • 2012 Provisional classification criteria for polymyalgia rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative†

    Bhaskar Dasgupta;Marco A. Cimmino;Hilal Maradit Kremers;Wolfgang A. Schmidt

  • 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

    Bhaskar Dasgupta;Marco A Cimmino;Hilal Maradit-Kremers;Wolfgang A Schmidt

  • Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.

    Carlo Salvarani;Giovanni Dolci;Marco Massari;Domenico Franco Merlo

  • Primary central nervous system vasculitis: analysis of 101 patients.

    Carlo Salvarani;Robert D. Brown;Kenneth T. Calamia;Teresa J. H. Christianson

  • Infliximab for Maintenance of Glucocorticosteroid-Induced Remission of Giant Cell Arteritis: A Randomized Trial

    Gary S. Hoffman;Maria C. Cid;Karen E. Rendt-Zagar;Peter A. Merkel

  • 2018 update of the EULAR recommendations for the management of Behçet’s syndrome

    Gulen Hatemi;Robin Christensen;Dongsik Bang;Bahram Bodaghi

  • Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis

    A Calin;B A C Dijkmans;P Emery;M Hakala

  • 2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative

    Christian Dejaco;Yogesh P. Singh;Pablo Perel;Andrew Hutchings

  • Takayasu's arteritis: A study of 104 Italian patients

    M. Vanoli;E. Daina;C. Salvarani;M. G. Sabbadini

Frequent Co-Authors

Gene G. Hunder
Gene G. Hunder Mayo Clinic
Maria C. Cid
Maria C. Cid University of Barcelona
Robert D. Brown
Robert D. Brown Mayo Clinic
Leonardo Punzi
Leonardo Punzi University of Padua
Roberto Gerli
Roberto Gerli University of Perugia
Roberto Caporali
Roberto Caporali University of Milan
Elisabeth Brouwer
Elisabeth Brouwer University Medical Center Groningen
John Huston
John Huston Mayo Clinic
Fabiola Atzeni
Fabiola Atzeni University of Messina

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees can open new doors for those interested in the medical field. Many students choose online programs for their flexibility and affordability, making it easier to balance work and study. Popular options include affordable medical billing and coding programs, which prepare graduates for administrative roles in the healthcare system. These positions are essential in ensuring hospitals and clinics run smoothly.

Nursing is another rewarding pathway. Those seeking advanced clinical positions might consider the cheapest np school online options, which can lead to careers as nurse practitioners. Meanwhile, individuals entering the field can begin with an online nursing school, combining foundational knowledge with hands-on practice.

For those aiming for leadership or research, online nursing doctoral programs offer a pathway to advanced opportunities without pausing your career. Each of these online degrees provides a unique entry point into healthcare, making it easier than ever to find the right fit for your professional goals.

Best Scientists Citing Carlo Salvarani

Trending Scientists

Recently Published Articles